Advertisement
Research Article
From pathogen to a commensal: modification of the Microbacterium nematophilum–Caenorhabditis elegans interaction during chronic infection by the absence of host insulin signalling
Maria Gravato-Nobre, Jonathan Hodgkin, Petros Ligoxygakis
Biology Open 2020 9: bio053504 doi: 10.1242/bio.053504 Published 7 October 2020

ABSTRACT

The nematode worm Caenorhabditis elegans depends on microbes in decaying vegetation as its food source. To survive in an environment rich in opportunistic pathogens, C. elegans has evolved an epithelial defence system where surface-exposed tissues such as epidermis, pharynx, intestine, vulva and hindgut have the capacity of eliciting appropriate immune defences to acute gut infection. However, it is unclear how the worm responds to chronic intestinal infections. To this end, we have surveyed C. elegans mutants that are involved in inflammation, immunity and longevity to find their phenotypes during chronic infection. Worms that grew in a monoculture of the natural pathogen Microbacterium nematophilum (CBX102 strain) had a reduced lifespan and vigour. This was independent of intestinal colonisation as both CBX102 and the derived avirulent strain UV336 were early persistent colonisers. In contrast, the long-lived daf-2 mutant was resistant to chronic infection, showing reduced colonisation and higher vigour. In fact, UV336 interaction with daf-2 resulted in a host lifespan extension beyond OP50, the Escherichia coli strain used for laboratory C. elegans culture. Longevity and vigour of daf-2 mutants growing on CBX102 was dependent on the FOXO orthologue DAF-16. Our results indicate that the interaction between host genotype and strain-specific bacteria determines longevity and health for C. elegans.

INTRODUCTION

Bacteria associated with the animal gut are important for gastrointestinal function (Fischbach, 2018). Intestinal bacteria contribute to metabolic activities and are involved in the absorption of nutrients, protection of mucosal surfaces and the regulation of the immune function of the gut (Fischbach, 2018). Quantitative and/or qualitative alteration of the intestinal microbiota underlie many inflammatory diseases as well as chronic gastrointestinal infections (CGIs), the latter being among the most common chronic diseases worldwide (Drossman, 2016). In the short term, CGIs can lead to altered mucosal and immune function (Drossman, 2016). In the longer term, CGIs cause impaired epithelial barrier function (a major factor of reduced health span in old age) and changes in intestinal microbiota (dysbiosis) that can ‘drive’ constitutive inflammation in conditions like intestinal bowel disease and enterocolitis (Sperber and Dekel 2010). Moreover, sustained inflammation can lead to intestinal cancer or may accelerate age-dependent neurodegeneration (Sperber and Dekel 2010). In this context, understanding how host genetics interacts with the intestinal microbiota in health and disease is an important aspect in managing long-term health span. However, it is also a complex problem with many biological parameters.

Accumulating evidence indicates that the health–disease balance in CGIs is determined by the interaction of four components (Stecher, 2015). These are (1) the infectious agent inducing the disease, (2) host genetics that will influence mucosal barrier function and pro- or anti-inflammatory responses, (3) the intestinal microbiota that can drive the disease when its composition changes and (4) diet, which influences all other components. Negative interaction of these factors can abolish normal intestinal barrier function leading to constant mucosal inflammation and reduced health and life expectancy (Finch, 2010). In contrast, non-inflammatory management can lead to extension of lifespan and healthspan (Hooper and Gordon, 2001). It is evident that interactions of the above four components generate a complex set of conditions, which makes it hard to untangle the layers of chronic disease and arrive at causality.

In the simplified system of the nematode worm, Caenorhabditis elegans, used in research laboratories around the world, the animal develops, feeds and ages in a bacterial monoculture. This means that food=microbiota=pathogen (or commensal) depending on the choice of bacterium. This condition ensures the ability to modify host genetics in vivo by keeping all other parameters important for CGIs in control. When the pathogen changes, so will the function of diet and microbiota, and thus the system enables us, in principle, to find the host genes that interact with a specific bacterial strain. In the wild, C. elegans is a bacterial feeder spending much of its life in decomposing vegetable matter and depending on microbes for food (Frézal and Félix, 2015). These microbes are ground by the pharynx before they subsequently enter the gut. To survive in an environment rich in potentially damaging microorganisms, C. elegans has evolved an epithelial defence system coupled with the ability to discriminate between pathogenic and edible bacteria (reviewed in Kim and Ewbank, 2018).

Important antimicrobial molecules participating in these defences include a group of proteins called invertebrate lysozymes (ILYS) and in particular ILYS-3, which is expressed in both the pharynx and the intestine (O'Rourke et al., 2006). ILYS-3 (invertebrate-specific but related to human epithelial antimicrobial peptides) contributes to the digestion of the large amount of peptidoglycan fragments generated by the worm's bacterial diet (either pathogenic or non-pathogenic) (Gravato-Nobre et al., 2016). Loss of ilys-3 results in colonisation of undigested bacteria from day 1 of adulthood in contrast to wild-type worms (Gravato-Nobre et al., 2016). The latter only display colonisation at very late stages of their life (Gravato-Nobre et al., 2016). Increased bacterial colonisation in ilys-3 mutants leads to a significant lifespan reduction (Gravato-Nobre et al., 2016).

The isolation of natural bacterial pathogens of C. elegans has permitted a glimpse of the defence mechanisms employed by the worm as well as the host–pathogen interactions triggering such mechanisms (see Hodgkin et al., 2000, 2013; Nicholas and Hodgkin, 2004). One such pathogen is Microbacterium nematophilum (Hodgkin et al., 2000). This Gram-positive bacterium adheres to the rectal and anal cuticle (Hodgkin et al., 2000) and induces inflammation, anal-region infection and tail swelling (Hodgkin et al., 2000; Parsons and Cipollo, 2014). Despite the fact that the most obvious response to infection is rectal colonisation and the induction of inflammation in the rectal tissues, this bacterium also establishes itself in the gut of the worm. In fact, host lethality caused by M. nematophulum is due to gut infection rather than rectal inflammation (Parsons and Cipollo, 2014). This makes it a good system to investigate effects that occur in the digestive tract associated with long-term gut colonisation. In particular, to identify how the long-term survival and health of the organism are influenced by chronic intestinal infection.

To explore this question, we tested C. elegans mutants induced by chemical mutagenesis or targeted deletion in signalling pathways known to be involved in immunity to M. nematophilum infection and/or C. elegans longevity. These mutant worms were grown using solely the M. nematophilum strain CBX102 (where CBX102 is the sole source of food=microbiota=pathogen). Using CBX102, we were able to separate estimated host survival probabilities into four categories in relation to ilys-3 and wild-type (N2) worms. We identified daf-2 as long-lived in conditions of chronic infection. Bacterial colonisation of CBX102 in N2 worms was increased compared to the laboratory E. coli strain OP50. However, colonisation in N2 per se was not the reason for pathogenesis as the non-virulent M. nematophilum strain UV336 did not curtail lifespan despite being able to colonise at the same levels as CBX102. Nevertheless, daf-2 worms were healthier and had reduced colonisation compared to normal worms. daf-2 health and longevity on CBX102 involved the canonical insulin-signalling pathway and were thus dependent on the FOXO orthologue daf-16, like many other daf-2-mediated effects. Finally, the non-pathogenic UV336 was able to support an extended lifespan for daf-2 beyond that observed when using OP50. These results indicate the complex and strain-specific interactions between intestinal bacteria and host genetics.

RESULTS

CGI curtails lifespan, reduces health and accelerates ageing in N2 worms

In our experimental CGI set-up, C. elegans develops, feeds and ages only with M. nematophilum, thus having the same microbial challenge from birth. Compared to standard laboratory food (E. coli strain OP50), the pathogenic M. nematophilum strain CBX102 reduced host lifespan (Fig. 1A) and health, measured by vigour of movement in liquid assays (Fig. 1B). The avirulent M. nematophilum UV336 strain (derived from CBX102 by UV mutagenesis, Akimkina et al., 2006), had the same level of bacterial colonisation as CBX102 (Fig. 1C) but in contrast to the latter, presented no negative impact on median lifespan (Fig. 1A) or health span (Fig. 1B), both of which were largely comparable to OP50. In this context, two strains of the same species behaved one as a pathogen (CBX102) and one as a commensal (UV336). Moreover, CBX102 accelerated mitochondrial fragmentation (Fig. S1), a sign of age-dependent stress in worms (Han et al., 2017).

Fig. 1.
Fig. 1.

Lifespan, health and bacterial colonisation of the reference strain N2 in UV336 versus CBX102. (A) Lifespan analysis at 25°C showing that CBX102 (red) significantly reduced average survival calculated using the Mantel-Cox log-rank test, 95% confidence interval (CI) compared to UV336 and OP50. The latter strains were statistically indistinguishable (NS). (B) Rigorous movement (thrashing) of animals grown on OP50, UV336 or CBX102 as a proxy for health was calculated as the number of body bends per second (BBPS). Tukey's multiple comparisons with one-way ANOVA test was performed. Worms on CBX102 were significantly less mobile than on OP50 or UV336. These were again, NS. (C) Distributions for the fluorescence intensity of SYTO13 in the intestine of animals on OP50 (E. coli), UV336 (M. nematophilum, non-inflammatory strain) and CBX102 (M. nematophilum, pathogenic strain) at 25°C. *, results of two Tukey's multiple comparisons one-way ANOVA tests, 99% CI. All panels: ***P<0.0001; NS, non-significant; n=25 animals/treatments/group; results are from three independent experiments.

CGI defines four lifespan groups of C. elegans mutants

To find worms that could outlive N2 under CGI while retaining their health, we tested C. elegans mutants induced by chemical mutagenesis, in signalling pathways known to be involved in immunity to infection and/or longevity. Our tests pertained to studying intestinal colonisation, lifespan and health/vigour. All strains were cultured from eggs in pure CBX102 and tested for bacterial colonisation.

The mutants tested were in genes of the p38 MAPK pathway (sek-1, nsy-1, pmk-1, kgb-1); TGF-β (dbl-1); ERK (sur-2), cuticle properties (sqt-3), bacterial killing (the lysozyme-encoding lys-3 and lys-7), pharyngeal-defective with enhanced bacterial colonisation of the intestine (phm-2), stress-specific regulators (hsf-1), apoptosis (the p53 homologue cep-1 and ced-1) and lifespan determinants (hif-1, vhl-1, age-1, eat-2, cik-1, daf-2). In terms of host survival probabilities, CGI separated the mutants tested into four categories: (A) those whose lifespan was shorter than ilys-3 mutants (Fig. 2A), (B) those that had lifespan comparable to ilys-3 (Fig. 2B), (C) those with life expectancy comparable to N2 (Fig. 2C) and (D) those that had an increased lifespan compared to N2 (Fig. 2D). Most of the time (but not always) bacterial colonisation negatively correlated with lifespan (Fig. S2). Table S1 gives a summary of alleles used, categorised into the four groups as above (A–D) and includes results on lifespan, health (vigorous movement) and bacterial colonisation along with extracted P-values.

Fig. 2.
Fig. 2.

Lifespan of C. elegans mutants define four groups on the pathogenic M. nematophilum strain CBX102. (A) Mutations that significantly shorten lifespan compared to ilys-3. TD50=5 days. (B) Mutations that shorten the lifespan to the same degree as ilys-3. (C) Mutations with the same TD50 as N2 (8–9 days). (D) Mutations that extended average survival compared to N2 (e.g. daf-2=44 days). N=100 animals per survival curve.

The daf-2 mutant is longer-lived and healthier than N2 under CGI

Of the mutants tested, only one mutant, in the insulin receptor, daf-2, was found to be living longer than N2 under CGI (Fig. 2D). This confirmed and extended observations for daf-2 longevity in OP50 (Kenyon et al., 1993) as well as acute infections by Staphylococcus aureus, Pseudomonas aeruginosa or Enterococcus faecalis (Garsin et al., 2003) and Salmonella typhimurium (Portal-Celhay et al., 2012). Bacterial colonisation of daf-2 was reduced compared to N2 (Fig. S2). It was also reduced compared to other normally long-lived mutants such as age-1 (Fig. S2). The latter is long-lived on OP50 (Friedman and Johnson, 1988) but had a lifespan indistinguishable to N2 on CBX102. (Fig. 2D). Finally, as Fig. S3 shows, daf-2 worms did not display inflammatory tail swelling like that reported for N2 (Hodgkin et al., 2000).

Despite the adverse effects of CBX102 on N2 lifespan (when compared to OP50), N2 median lifespan on UV336 and OP50 were statistically indistinguishable (Fig. 3A). The survival pattern of daf-2 mutants on CBX102 was statistically comparable to that of daf-2 on E. coli OP50 (Fig. 3B). Compared to N2 on CBX102, daf-2 worms were still longer-lived (compare Fig. 3A and B). Notably, daf-2 lifespan was extended on UV336 compared to daf-2 on CBX102 even beyond the TD50 and maximum lifespan limits defined by OP50 (Fig. 3B). This boosting effect on lifespan by UV336 over and above OP50 was not observed in N2 (Fig. 3A). This result showed that the genotype of the host can modify the effect of a bacterial strain and this interaction determines lifespan. Conversely, any effect of a bacterial species is strain specific.

Fig. 3.
Fig. 3.

The daf-2 mutant modifies the effects on lifespan of M. nematophilum strains. (A) Lifespan of N2 on M. nematophilum CBX102 under CGI was significantly reduced (TD50=11 days) when compared to both the derived M. nematophilum UV336 strain and E. coli OP50 that produced identical TD50 (19 days). (B) Lifespan of daf-2 on M. nematophilum CBX102 under CGI (TD50=33) was statistically indistinguishable (P=0.4531) from OP50 (TD50=36). In contrast, lifespan on UV336 was significantly increased (P<0.0001; TD50=49). For experiments involving the temperature sensitive daf-2, lifespan assays started at day 0 when animals were age-synchronized by bleach. Embryos were then left at 15°C on the appropriate bacterial diet until day 5. Day 5 marks the L4-to-adult transition and the time when plates were transferred to 25°C. The graph is A is the same experiment as in Fig. 1A. All experiments shown in Figs 1 and 3 were conducted in parallel. N=25 per treatment. Results are from three independent experiments.

Daf-16 is required for the longevity and health of daf-2 mutants under CGI

Lifespan extension through the DAF-2 insulin-signalling pathway in C. elegans occurs by de-repression of the fork-head transcription factor DAF-16, which is normally under negative regulation by DAF-2. Strong loss-of-function alleles of daf-16 such as mgDf47 and mu86 suppressed the long-lived phenotype of daf-2 under CGI with CBX102 making the double daf-16;daf-2 statistically indistinguishable from N2 (Fig. 4). Moreover, loss of DAF-16 suppressed the vigorous thrashing ability of daf-2 making again the double daf-16;daf-2 statistically indistinguishable in its vigour from N2 (Fig. S4). As expected from the above, daf-16 on its own, exhibited a comparable degree of survival to CGI as N2 worms. Therefore, in C. elegans, the DAF-2/DAF-16 axis is important for maintaining longevity and health under CGI by a natural pathogen.

Fig. 4.
Fig. 4.

FOXO mediates the extension of daf-2 lifespan on CBX102 under CGI. The daf-2-mediated lifespan extension on CBX102 was suppressed by daf-16/FOXO, using two mutants (mu86 and mgDf47) of daf-16. We found that when compared to each other and to N2, daf-16, daf-2 double mutants and N2 had a lifespan with identical TD50 (12 days) on CBX102. This was also the lifespan (TD50) of daf-16(mu86) alone (12 days). In contrast, the lifespan of daf-2 on CBX102 under CGI was significantly different (TD50=33, P<0.0001). For experiments involving the temperature sensitive daf-2, lifespan assays started at day 0 when animals were age-synchronized by bleach. Embryos were then left at 15°C on the appropriate bacterial diet until day 5. Day 5 marks the L4-to-adult transition and the time when plates were transferred to 25°C. N=25 per treatment. Results are from three independent experiments.

DISCUSSION

We wanted to develop a simple model to test host longevity and health under CGI. Caenorhabditis elegans is such a model since microbiota=pathogen=food as the worm is a bacterial feeder and its laboratory culture is typically a bacterial mono-association.

Our work shows where longevity and immunity converge under CGI. Our data indicate that the insulin-signalling pathway modulates intestinal colonisation to affect long-term host survival. How long the host will live, however, is also dependent on the strain-specific pathogenicity of the bacteria on which C. elegans is feeding. The natural pathogen M. nematophilum strain CBX102 curtailed the lifespan and health of N2 wild-type worms but strain UV336 was statistically indistinguishable from E. coli OP50, the ‘normal’ lab food. Inactivation of the insulin receptor in daf-2 made worms longer-lived, healthier and physiologically younger on CBX102. This correlated with reduced colonisation (Figs S3 and S5). In addition, UV336 extended daf-2 lifespan even beyond what has been seen with E. coli OP50, acting as a lifespan-extending bacterium when interacting with this host genetic background. More work is needed to identify the genetic differences between the two M. nematophilum strains and how lack of insulin host signalling modifies these bacterial strains and their properties.

The insulin pathway-mediated modification of a pathogen to a commensal (CBX102) or to a lifespan-extending bacterium (UV336) may have parallels in other model organisms. Recent evidence in mice has shown that inducing insulin resistance through dietary iron drove conversion of a pathogen to a commensal. Specifically, insulin resistance converted the enteric pathogen Citrobacter to a commensal (Sanchez et al., 2018). There, reduced intestinal glucose absorbance was crucial for Citrobacter to be a commensal (Sanchez et al., 2018). More work is needed to determine if systemic glucose levels and/or intestinal glucose absorption also play a role in C. elegans and how this relates to the worm insulin pathway. Reduced glucose levels increase lifespan in worms (Watts and Ristow, 2017). Reducing glycolysis has been shown to induce mitochondrial OXPHOS to generate a lifespan-extending reactive oxygen species (ROS) signal (Schulz et al., 2007) while increased levels have the opposite effect (Schulz et al., 2007; Zarse et al., 2012). Limitations in this comparison include the fact that the single bacterium microbiota we have studied is different than the complex one in mice. Moreover, the insulin pathway in worms and mammals may have differences in biochemical terms (reviewed in Watts and Ristow, 2017).

Taken together, our results and recent data from mice (Sanchez et al., 2018) show that the consequences a bacterium will cause to a host exist as a continuum. Thus, host genetics is an important factor determining where a bacterium may lie in this continuum. Our data show that interaction between the worm and its bacterial food will be shaped by both host genes and the bacterium at the strain level. In our system, the most prominent host proponent shaping this interaction is the insulin-FOXO-dependent signalling pathway. In this context, C. elegans is an excellent model to design genetic screens and identify worm mutants that suppress the UV336-dependent extension of the daf-2 longevity phenotype.

MATERIALS AND METHODS

Caenorhabditis elegans strains

All strains (Table S1) were provided by the Caenorhabditis Genetic Center (CGC), University of Minnesota, MN, USA, and maintained at 20°C, unless otherwise noted. The CGC is supported by the National Institutes of Health Office of Research Infrastructure Programs (P40 OD010440).

Bacteria growth conditions

Escherichia coli OP50 or M. nematophilum (CBX102, UV336) cultures were grown in LB at 37°C. Bacterial lawns were prepared by spreading 100 μl of an overnight culture on a 6 cm diameter NGM plate. Plates were incubated overnight at room temperature.

Immunity and longevity assays

CBX102 assays were performed at 25°C, unless otherwise noted, as previously described (Gravato-Nobre et al., 2016). To test or validate the immunity or longevity phenotypes of daf-2 (e1370), worms were raised on CBX102 or OP50 to the L4 stage at the permissive temperature (15°C) and shifted to the restrictive temperature of 25°C. Worms were age-synchronised by bleaching and embryos were incubated at 25°C on NGM agar plates with lawns of E. coli OP50 or M. nematophilum CBX102. The embryonic stage (day of bleach) was designated as Day 0. A total of 125 worms were used per lifespan assay. On day 2, 25 animals were transferred to each NGM plate. Animals were scored daily and transferred to fresh lawns every other day. Death was defined when an animal no longer responded to touch. Worms that died of bagging or crawled off the plates were excluded from the analysis. For each mutant population and bacterial lawn, the time required for 50% of the animals to die (TD50) was compared to that of the control populations using a t-test. A P-value<0.05 was considered significantly different from the control.

SYTO 13 labelling

Overnight bacterial cultures were concentrated 10× by spinning them at 2500 rpm, and their pellet suspended in 1 ml of TBS containing 3 μl of SYTO 13. Bacterial colonisation was determined by exposing the animals to SYTO13-labelled CBX102 or OP50. To allow for their complete post-embryonic development, animals were left on CBX102 lawns at 15°C until most mutant animals reached L4, after which, they were shifted to 25°C for another day. On day 7, one-day-old adult worms were exposed to SYTO 13-labelled CBX102. Worms were visualised after 20 h of feeding on SYTO 13-labeled CBX102. Live worms were mounted on a glass slide in 25 μM tetramisole on a 2% agarose pad and examined using a Leica SP5 confocal microscope. Quantification of SYTO13 was performed in the intestine using a Leica TCS-SP5 Laser Scanning Confocal microscope with a x63 oil immersion lens and the Argon 488 laser. The focal plane with the highest GFP signal was used to measure fluorescence intensity within a ROI set to 0.4 μ thickness and a 10 μ or 40 μ diameter, for L1 larvae or adults, respectively. To make comparisons across samples, data are presented in box plots that define interquartile range (25% of the data above or below the median), expression range (bars) and the median (thick line). Identical exposure settings were used for all genotypes. Fluorescence was limited to 495/512 nm to diminish background autofluorescence from the animals. For each experiment, and on the same day, we imaged 10–15 animals per treatment.

Thrashing assays

One-day-old adults were placed in a drop of M9 and allowed to recover for 40 s (to avoid behaviour associated with stress), after which animals were video recorded for 30 s. The number of body bends per second (BBPS) was determined by importing captured video images to ImageJ and by using wrMTrck plugin developed by Jesper S. Pederson. (http://www.phage.dk/plugins/wrmtrck.html). More than 20 animals were used in each treatment. Thrashing experiments were done in triplicates. All statistical analysis data was performed using GraphPad Prism software.

Footnotes

  • Competing interests

    The authors declare no competing or financial interests.

  • Author contributions

    Conceptualization: M.G.-N., P.L.; Methodology: M.G.-N.; Formal analysis: M.G.-N., J.H., P.L.; Investigation: M.G.-N; Writing - original draft: P.L.; Writing - review & editing: M.G.-N., J.H., P.L.; Supervision: J.H., P.L.; Project administration: P.L.; Funding acquisition: P.L.

  • Funding

    EP Abraham Cephalosporin Trust grant [CF 319] (to P.L.).

  • Supplementary information

    Supplementary information available online at https://bio.biologists.org/lookup/doi/10.1242/bio.053504.supplemental

  • Received May 19, 2020.
  • Accepted June 12, 2020.
http://creativecommons.org/licenses/by/4.0

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.

References

  1. ↵
    1. Akimkina, T.,
    2. Yook, K.,
    3. Curnock, S. and
    4. Hodgkin, J.
    (2006). Genome characterization, analysis of virulence and transformation of Microbacterium nematophilum, a coryneform pathogen of the nematode Caenorhabditis elegans. FEMS Microbiol. Lett. 264, 145-151. doi:10.1111/j.1574-6968.2006.00469.x
    OpenUrlCrossRefPubMed
  2. ↵
    1. Drossman, D. A.
    (2016). Functional gastrointestinal disorders: history, pathophysiology, clinical features and Rome IV. Gastroenterology 150, p1262. doi:10.1053/j.gastro.2016.02.032
    OpenUrlCrossRef
  3. ↵
    1. Finch, C. E.
    (2010). Evolution in health and medicine Sackler colloquium: evolution of the human lifespan and diseases of aging: roles of infection, inflammation, and nutrition. Proc. Natl. Acad. Sci. USA 107, 1718-1724. doi:10.1073/pnas.0909606106
    OpenUrlAbstract/FREE Full Text
  4. ↵
    1. Fischbach, M. A.
    (2018) Microbiome: Focus on Causation and Mechanism. Cell 174, 785-790. doi:10.1016/j.cell.2018.07.038
    OpenUrlCrossRefPubMed
  5. ↵
    1. Frézal, L. and
    2. Félix, M.-A.
    (2015). The natural history of model organisms: C. elegans outside the Petri dish. eLife 4, e05849. doi:10.7554/elife.05849
    OpenUrlCrossRefPubMed
  6. ↵
    1. Friedman, D. B. and
    2. Johnson, T. E.
    (1988). A mutation in the age-1 gene in Caenorhabditis elegans lengthens life and reduces hermaphrodite fertility. Genetics 118, 75-86.
    OpenUrlAbstract/FREE Full Text
  7. ↵
    1. Garsin, D. A.,
    2. Villanueva, J. M.,
    3. Begun, J.,
    4. Kim, D. H.,
    5. Sifri, C. D.
    6. Calderwood, S. B.
    7. Ruvkun, G. and
    8. Ausubel, F. M.
    (2003). Long-lived C. elegans daf-2 mutants are resistant to bacterial pathogens. Science 300, 1921. doi:10.1126/science.1080147
    OpenUrlFREE Full Text
  8. ↵
    1. Gravato-Nobre, M. J.,
    2. Vaz, F.,
    3. Filipe, S.,
    4. Chalmers, R. and
    5. Hodgkin, J.
    (2016). The invertebrate lysozyme effector ILYS-3 is systemically activated in response to danger signals and confers antimicrobial protection in C. elegans. PLoS Pathog. 12, e1005826. doi:10.1371/journal.ppat.1005826
    OpenUrlCrossRef
  9. ↵
      (2017) Microbial genetic composition tunes host longevity. Cell 169, 1249-1262.
      OpenUrlCrossRefPubMed
    1. ↵
      1. Hodgkin, J.,
      2. Kuwabara, P. E. and
      3. Corneliussen, B.
      (2000). A novel bacterial pathogen, microbacterium nematophilum, induces morphological change in the nematode C. elegans. Curr. Biol. 10, 1615-1618. doi:10.1016/S0960-9822(00)00867-8
      OpenUrlCrossRefPubMedWeb of Science
    2. ↵
      1. Hodgkin, J.,
      2. Félix, M.-A.,
      3. Clark, L. C.,
      4. Stroud, D. and
      5. Gravato-Nobre, M. J.
      (2013). Two Leucobacter strains exert complementary virulence on Caenorhabditis including death by worm-star formation. Curr. Biol. 23, 2157-2161. doi:10.1016/j.cub.2013.08.060
      OpenUrlCrossRefPubMed
    3. ↵
      1. Hooper, L. V. and
      2. Gordon, J. I.
      (2001). Commensal host-bacterial relationships in the gut. Science 292, 1115-1118. doi:10.1126/science.1058709
      OpenUrlAbstract/FREE Full Text
    4. ↵
      1. Kenyon, C.,
      2. Chang, J.,
      3. Gensch, E.,
      4. Rudner, A. and
      5. Tabtiang, R.
      (1993). A C. elegans mutant that lives twice as long as wild type. Nature 366, 461-464. doi:10.1038/366461a0
      OpenUrlCrossRefPubMedWeb of Science
    5. ↵
      1. Kim, D. H. and
      2. Ewbank, J. J.
      (2018). Signaling in the innate immune response. WormBook, 1-35. doi:10.1895/wormbook.1.83.2
      OpenUrlCrossRef
    6. ↵
      1. Nicholas, H. R. and
      2. Hodgkin, J.
      (2004). The ERK MAP kinase cascade mediates tail swelling and a protective response to rectal infection in C. elegans. Curr. Biol. 14, 1256-1261. doi:10.1016/j.cub.2004.07.022
      OpenUrlCrossRefPubMedWeb of Science
    7. ↵
      1. O'Rourke, D.,
      2. Baban, D.,
      3. Demidova, M.,
      4. Mott, R. and
      5. Hodgkin, J.
      (2006). Genomic clusters, putative pathogen recognition molecules, and antimicrobial genes are induced by infection of C. elegans with M. nematophilum. Genome Res. 16, 1005-1016. doi:10.1101/gr.50823006
      OpenUrlAbstract/FREE Full Text
    8. ↵
      1. Parsons, L. M. and
      2. Cipollo, J.
      (2014). Oral ingestion of Microbacterium nematophilum leads to anal-region infection in Caenorhabditis elegans. Microbes Infect. 16, 356-361. doi:10.1016/j.micinf.2014.01.002
      OpenUrlCrossRef
    9. ↵
      1. Portal-Celhay, C.,
      2. Bradley, E. R. and
      3. Blaser, M. J.
      (2012). Control of intestinal bacterial proliferation in regulation of lifespan in Caenorhabditis elegans. BMC Microbiol. 12, 49-56. doi:10.1186/1471-2180-12-49
      OpenUrlCrossRefPubMed
    10. ↵
      1. Sanchez, K. K.,
      2. Chen, G. Y.,
      3. Schieber, A. MP.
      4. Redford, S. E.,
      5. Shokhirev, M. N.,
      6. Leblanc, M.,
      7. Lee, Y. M. and
      8. Ayres, J. S.
      (2018). Cooperative metabolic adaptations in the host can favor asymptomatic infection and select for attenuated virulence in an enteric pathogen. Cell 175, 146-158.e15. doi:10.1016/j.cell.2018.07.016
      OpenUrlCrossRefPubMed
    11. ↵
      1. Schulz, T. J.,
      2. Zarse, K.,
      3. Voigt, A.,
      4. Urban, N.,
      5. Birringer, M. and
      6. Ristow, M.
      (2007). Glucose restriction extends Caenorhabditis elegans life span by inducing mitochondrial respiration and increasing oxidative stress. Cell Metab. 6, 280-293. doi:10.1016/j.cmet.2007.08.011
      OpenUrlCrossRefPubMedWeb of Science
    12. ↵
      1. Sperber, A. D. and
      2. Dekel, R.
      (2010). Irritable bowel syndrome and co-morbid gastrointestinal and extra-gastrointestinal functional syndromes. J. Neurogastroenterol. Motil. 16, 113-119. doi:10.5056/jnm.2010.16.2.113
      OpenUrlCrossRefPubMed
    13. ↵
      1. Stecher, B.
      (2015). The roles of inflammation, nutrient availability and the commensal microbiota in enteric pathogen infection. Microbiol. Spectr. 3, 1-17.
      OpenUrl
    14. ↵
      1. Watts, J. L. and
      2. Ristow, M.
      (2017). Lipid and carbohydrate metabolism in Caenorhabditis elegans. Genetics 207, 413-446. doi:10.1534/genetics.117.300106
      OpenUrlAbstract/FREE Full Text
    15. ↵
      1. Zarse, K.,
      2. Schmeisser, S.,
      3. Groth, M.,
      4. Priebe, S.,
      5. Beuster, G.
      6. Kuhlow, D.,
      7. Guthke, R.,
      8. Platzer, M.,
      9. Kahn, C. R. and
      10. Ristow, M.
      (2012). Impaired insulin/IGF1signaling extends life span by promoting mitochondrial L-proline catabolism to induce a transient ROS signal. Cell Metab. 15, 451-465. doi:10.1016/j.cmet.2012.02.013
      OpenUrlCrossRefPubMedWeb of Science
    View Abstract
    Back to top

    RSSRSS

    Keywords

     Download PDF

    Email
    Research Article
    From pathogen to a commensal: modification of the Microbacterium nematophilum–Caenorhabditis elegans interaction during chronic infection by the absence of host insulin signalling
    Maria Gravato-Nobre, Jonathan Hodgkin, Petros Ligoxygakis
    Biology Open 2020 9: bio053504 doi: 10.1242/bio.053504 Published 7 October 2020
    del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
    Citation Tools
    Alerts

    Article Navigation

    Other journals from The Company of Biologists

    Advertisement

    Biology Open and COVID-19

    We are aware that the COVID-19 pandemic is having an unprecedented impact on researchers worldwide. The Editors of all The Company of Biologists’ journals have been considering ways in which we can alleviate concerns that members of our community may have around publishing activities during this time. Read about the actions we are taking at this time.

    Please don’t hesitate to contact the Editorial Office if you have any questions or concerns.

    Virtual events at The Company of Biologists

    In September, our sister journal Development held its bi-yearly Journal Meeting. Known for its excellent social opportunities, the Meeting this year was recreated for a virtual format. Participants say it was the most ‘lifelike’ virtual meeting they’ve attended – find out more about how we’re reimagining our events virtually.   

    Interviews – Tiyasha Sarkar and Komal Panchal

    We champion the next generation of biologists and are pleased to give first authors the chance to discuss their research in interviews alongisde their papers. In our latest issue, Tiyasha talks about her work on neurological disorders and Komal discusses her research on Alzheimer’s disease.

    Cover article - Cell-to-cell communication mediates glioblastoma progression in Drosophila

    Issue 9’s cover is a glioblastoma single brain hemisphere section from Drosophila third-instar larvae, from a study by Portela and colleagues.